Sensus Healthcare, Inc. (SRTS)
USD 4.58
(-0.22%)
USD 4.58
(-0.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 24.4 Million | 44.53 Million | 27.04 Million | 9.57 Million | 27.26 Million | 26.42 Million |
| Cost of Revenue | 10.34 Million | 14.9 Million | 10.05 Million | 4.32 Million | 9.7 Million | 9.51 Million |
| Gross Profit | 14.06 Million | 29.62 Million | 16.98 Million | 5.24 Million | 17.55 Million | 16.91 Million |
| Operating Expenses | 14.44 Million | 14.79 Million | 12.86 Million | 13.48 Million | 19.52 Million | 18.91 Million |
| Selling, General and Administrative Expenses | 10.76 Million | 11.33 Million | 9.43 Million | 9.32 Million | 13.1 Million | 12.65 Million |
| Research and Development Expenses | 3.67 Million | 3.46 Million | 3.43 Million | 4.15 Million | 6.41 Million | 6.26 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 24.78 Million | 29.7 Million | 22.92 Million | 17.81 Million | 29.23 Million | 28.43 Million |
| Operating Income | -382 Thousand | 14.83 Million | 4.12 Million | -8.23 Million | -1.96 Million | -2 Million |
| Interest Expense | - | 2000.00 | 1000.00 | 14.23 Thousand | - | 156.68 Thousand |
| Income Tax Expense | 167 Thousand | 3.74 Million | -613 Thousand | -2.12 Million | -545.71 Thousand | 139.27 Thousand |
| Earnings before Tax | 652 Thousand | 27.99 Million | 4.11 Million | -6.83 Million | -1.7 Million | -2.02 Million |
| Net Income | 485 Thousand | 24.24 Million | 4.11 Million | -4.71 Million | -1.15 Million | -2.02 Million |
| Earnings Per Share Basic | 0.03 | 1.47 | 0.25 | -0.29 | -0.07 | -0.14 |
| Earnings Per Share Diluted | 0.03 | 1.46 | 0.25 | -0.29 | -0.07 | -0.14 |
| Weighted Average Shares Outstanding | 16.25 Million | 16.48 Million | 16.47 Million | 16.43 Million | 16.23 Million | 14.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 16.26 Million | 16.61 Million | 16.5 Million | 16.43 Million | 16.23 Million | 14.11 Million |
| Gross Margin | 0.58 | 0.67 | 0.63 | 0.55 | 0.64 | 0.64 |
| EBIT Margin | 0.00 | 0.34 | 0.15 | -1.00 | -0.06 | -0.07 |
| Profit Margin | 0.02 | 0.54 | 0.15 | -0.49 | -0.04 | -0.08 |
| EBITDA | 30 Thousand | 14.83 Million | 4.73 Million | -6.09 Million | -1.15 Million | -1.2 Million |
| Earnings Before Tax Margin | -0.02 | 0.33 | 0.15 | -0.86 | -0.07 | -0.08 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 9.23 Million | 10.66 Million | 24.4 Million | 12.56 Million | 3.89 Million | 4.52 Million |
| Cost of Revenue | 3.81 Million | 4 Million | 10.34 Million | 4.73 Million | 1.9 Million | 1.9 Million |
| Gross Profit | 5.42 Million | 6.66 Million | 14.06 Million | 7.82 Million | 1.98 Million | 2.61 Million |
| Operating Expenses | 3.44 Million | 3.77 Million | 14.44 Million | 2.25 Million | 3.88 Million | 3.74 Million |
| Selling, General and Administrative Expenses | 2.57 Million | 2.84 Million | - | 1.57 Million | 2.8 Million | 2.92 Million |
| Research and Development Expenses | 866 Thousand | 926 Thousand | - | 678 Thousand | 1.08 Million | 822 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 7.25 Million | 7.77 Million | 24.78 Million | 6.98 Million | 5.79 Million | 5.65 Million |
| Operating Income | 1.98 Million | 2.88 Million | -382 Thousand | 5.57 Million | -1.89 Million | -1.12 Million |
| Interest Expense | - | - | - | 243 Thousand | - | - |
| Income Tax Expense | 579 Thousand | 827 Thousand | 167 Thousand | 1.59 Million | -125 Thousand | -502 Thousand |
| Earnings before Tax | 2.19 Million | 3.1 Million | 652 Thousand | 5.8 Million | -1.57 Million | -882 Thousand |
| Net Income | 1.61 Million | 2.27 Million | 485 Thousand | 4.21 Million | -1.45 Million | -380 Thousand |
| Earnings Per Share Basic | 0.10 | 0.14 | - | 0.26 | -0.09 | -0.02 |
| Earnings Per Share Diluted | 0.10 | 0.14 | - | 0.26 | -0.09 | -0.02 |
| Weighted Average Shares Outstanding | 16.29 Million | 16.29 Million | 16.25 Million | 16.27 Million | 16.27 Million | 16.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 16.33 Million | 16.31 Million | 16.26 Million | 16.27 Million | 16.27 Million | 16.24 Million |
| Gross Margin | 0.59 | 0.62 | 0.58 | 0.62 | 0.51 | 0.58 |
| EBIT Margin | 0.22 | 0.28 | - | 0.45 | -0.42 | -0.25 |
| Profit Margin | 0.17 | 0.21 | 0.02 | 0.34 | -0.37 | -0.08 |
| EBITDA | 2.06 Million | 3 Million | - | 5.63 Million | -1.61 Million | -1.12 Million |
| Earnings Before Tax Margin | 0.21 | 0.27 | -0.02 | 0.44 | -0.49 | -0.25 |
ADVENZYMES
0QYE
KOKUYOCMLN
OIIIF
AHLUCONT
2360